
electroCore Investor Relations Material
Latest events

Q1 2025
electroCore
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from electroCore Inc
Access all reports
electroCore Inc is a commercial-stage medical technology company that develops and markets non-invasive neuromodulation devices. Its primary product, a handheld device, uses electrical stimulation to target the vagus nerve for the treatment of various conditions, including migraines and cluster headaches. The company’s technology is designed to offer patients a non-drug, non-invasive alternative for pain management and neurological disorders. electroCore is also exploring the potential use of its platform in other therapeutic areas such as respiratory diseases and inflammatory conditions. The company is headquartered in Rockaway, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
ECOR
Country
🇺🇸 United States